Muraglitazar
Muraglitazar (BMS-298585) is a potent dual agonist of PPARα and PPARγ, with EC50 values of 320 nM and 110 nM, respectively. It has been investigated in preclinical research for the treatment of type 2 diabetes and dyslipidemia, demonstrating efficacy in both in vitro assays and in vivo animal models.
Product Specifications
CAS Number
331741-94-7
Product Name Alternative
BMS298585, BMS-298585, BMS 298585, Pargluva, Muraglitazar, human PPARγ, hPPARα
Field of Research
Metabolism Research, Molecular Biology
Purity
99.17% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (6.39 mM) ; DMSO:128.8 mg/mL (249.35 mM)
Smiles
C (COC1=CC=C (CN (C (OC2=CC=C (OC) C=C2) =O) CC (O) =O) C=C1) C=3N=C (OC3C) C4=CC=CC=C4
Molecular Formula
C29H28N2O7
Molecular Weight
516.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog